Marijuana lab testing under scrutiny amid recalls, differing rules
By Kate Robertson for MJBizDaily
State marijuana regulators, producers and other stakeholders are grappling with how to safeguard consumers at a time when lab-testing requirements and enforcement differ dramatically nationwide and large-scale product recalls are common.
Each state currently takes its own approach to medical and adult-use cannabis lab testing for potency and contaminants as well as production standards and inspection – a situation that has led to inconsistent testing regulations and questions over whether consumer safety is a top priority for companies and regulators.
Steph Sherer, founder of Washington DC-based medical cannabis advocacy group Americans for Safe Access (ASA), said the patchwork approach to testing is a symptom of federal prohibition.
“If this was a legal commodity in the United States, it would be subject to standard testing,” Sherer told MJBizDaily in an interview.
Share this page
